Estimates Revisions Lexeo Therapeutics, Inc.
Stocks
LXEO
US52886X1072
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.820 USD | -4.55% |
|
+2.77% | -51.46% |
| 06-30 | Lexeo Therapeutics, Inc. - Special Call | |
| 06-17 | Lexeo Therapeutics Publishes Phase I/Ii Data for Lx2006 in Friedreich Ataxia in Jama Cardiology | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- LXEO Stock
- Consensus Lexeo Therapeutics, Inc.
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
